Clinical Trial Update: A Drug-drug Interaction Study Between BMS-663068 and Oral Contraceptives in Healthy Female Volunteers (DDI) [Phase 1]

View source ↗

Summary

Phase 1 drug-drug interaction study evaluating BMS-663068 with oral contraceptives in healthy female volunteers has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• BMS-663068 (BMS-626529)
• Oral contraceptives (combined oral contraceptives)

Snippet

Sponsor: ViiV Healthcare | Conditions: Infection, Human Immunodeficiency Virus | Phase 1 | Status: COMPLETED